

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 4.75523992 |
| 2 | L-phenylalanine catabolic process (GO:0006559) | 4.75523992 |
| 3 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 4.59311664 |
| 4 | L-phenylalanine metabolic process (GO:0006558) | 4.59311664 |
| 5 | aromatic amino acid family catabolic process (GO:0009074) | 4.53603912 |
| 6 | ribosome assembly (GO:0042255) | 4.48037400 |
| 7 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 4.41705666 |
| 8 | aldehyde catabolic process (GO:0046185) | 4.41078835 |
| 9 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 4.40797156 |
| 10 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 4.32376475 |
| 11 | tryptophan catabolic process (GO:0006569) | 4.27439047 |
| 12 | indole-containing compound catabolic process (GO:0042436) | 4.27439047 |
| 13 | indolalkylamine catabolic process (GO:0046218) | 4.27439047 |
| 14 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 4.24843766 |
| 15 | negative regulation of ligase activity (GO:0051352) | 4.05295541 |
| 16 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 4.05295541 |
| 17 | tryptophan metabolic process (GO:0006568) | 4.03328002 |
| 18 | regulation of meiosis I (GO:0060631) | 4.01570727 |
| 19 | urea metabolic process (GO:0019627) | 4.01477295 |
| 20 | urea cycle (GO:0000050) | 4.01477295 |
| 21 | cysteine metabolic process (GO:0006534) | 3.90105796 |
| 22 | DNA double-strand break processing (GO:0000729) | 3.88772121 |
| 23 | bile acid biosynthetic process (GO:0006699) | 3.86728225 |
| 24 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.83902395 |
| 25 | regulation of helicase activity (GO:0051095) | 3.83315756 |
| 26 | kynurenine metabolic process (GO:0070189) | 3.81293583 |
| 27 | regulation of cellular amino acid metabolic process (GO:0006521) | 3.79022843 |
| 28 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 3.78493234 |
| 29 | regulation of attachment of spindle microtubules to kinetochore (GO:0051988) | 3.73717974 |
| 30 | cullin deneddylation (GO:0010388) | 3.72038855 |
| 31 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 3.72005180 |
| 32 | establishment of integrated proviral latency (GO:0075713) | 3.70480412 |
| 33 | nitrogen cycle metabolic process (GO:0071941) | 3.66774354 |
| 34 | regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090266) | 3.64918593 |
| 35 | regulation of mitotic spindle checkpoint (GO:1903504) | 3.64918593 |
| 36 | positive regulation of ligase activity (GO:0051351) | 3.64558378 |
| 37 | DNA replication checkpoint (GO:0000076) | 3.64553859 |
| 38 | transcription from mitochondrial promoter (GO:0006390) | 3.63916892 |
| 39 | histone exchange (GO:0043486) | 3.62235641 |
| 40 | glyoxylate metabolic process (GO:0046487) | 3.60319549 |
| 41 | DNA damage response, detection of DNA damage (GO:0042769) | 3.58151658 |
| 42 | peptidyl-glutamic acid carboxylation (GO:0017187) | 3.56562053 |
| 43 | protein carboxylation (GO:0018214) | 3.56562053 |
| 44 | histone mRNA metabolic process (GO:0008334) | 3.54898437 |
| 45 | rRNA modification (GO:0000154) | 3.54017106 |
| 46 | regulation of ubiquitin-protein transferase activity (GO:0051438) | 3.52544062 |
| 47 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 3.48807969 |
| 48 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 3.48807969 |
| 49 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 3.48807969 |
| 50 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 3.47136385 |
| 51 | serine family amino acid catabolic process (GO:0009071) | 3.47130570 |
| 52 | sulfur amino acid catabolic process (GO:0000098) | 3.44148990 |
| 53 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 3.43797935 |
| 54 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 3.42745180 |
| 55 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 3.42745180 |
| 56 | regulation of ligase activity (GO:0051340) | 3.41905501 |
| 57 | DNA catabolic process, exonucleolytic (GO:0000738) | 3.41287987 |
| 58 | glycine metabolic process (GO:0006544) | 3.39288571 |
| 59 | protein targeting to mitochondrion (GO:0006626) | 3.39032160 |
| 60 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 3.38073438 |
| 61 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 3.38073438 |
| 62 | aromatic amino acid family metabolic process (GO:0009072) | 3.37922608 |
| 63 | regulation of mitochondrial translation (GO:0070129) | 3.37678510 |
| 64 | high-density lipoprotein particle remodeling (GO:0034375) | 3.36978698 |
| 65 | spindle checkpoint (GO:0031577) | 3.36652990 |
| 66 | negative regulation of fibrinolysis (GO:0051918) | 3.36009995 |
| 67 | mitotic spindle checkpoint (GO:0071174) | 3.34327247 |
| 68 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 3.34110318 |
| 69 | negative regulation of mitotic sister chromatid separation (GO:2000816) | 3.30196819 |
| 70 | negative regulation of sister chromatid segregation (GO:0033046) | 3.30196819 |
| 71 | negative regulation of mitotic metaphase/anaphase transition (GO:0045841) | 3.30196819 |
| 72 | negative regulation of metaphase/anaphase transition of cell cycle (GO:1902100) | 3.30196819 |
| 73 | negative regulation of mitotic sister chromatid segregation (GO:0033048) | 3.30196819 |
| 74 | regulation of cholesterol esterification (GO:0010872) | 3.28743269 |
| 75 | DNA replication-independent nucleosome organization (GO:0034724) | 3.27315061 |
| 76 | DNA replication-independent nucleosome assembly (GO:0006336) | 3.27315061 |
| 77 | synapsis (GO:0007129) | 3.27062701 |
| 78 | mitochondrial RNA metabolic process (GO:0000959) | 3.26605145 |
| 79 | establishment of viral latency (GO:0019043) | 3.26355042 |
| 80 | negative regulation of chromosome segregation (GO:0051985) | 3.26289229 |
| 81 | rRNA methylation (GO:0031167) | 3.25052200 |
| 82 | cellular biogenic amine catabolic process (GO:0042402) | 3.24494503 |
| 83 | amine catabolic process (GO:0009310) | 3.24494503 |
| 84 | DNA strand elongation involved in DNA replication (GO:0006271) | 3.22231512 |
| 85 | mitotic metaphase plate congression (GO:0007080) | 3.21931146 |
| 86 | cellular ketone body metabolic process (GO:0046950) | 3.21350761 |
| 87 | nuclear pore complex assembly (GO:0051292) | 3.20340413 |
| 88 | bile acid metabolic process (GO:0008206) | 3.19080123 |
| 89 | S-adenosylmethionine metabolic process (GO:0046500) | 3.17800120 |
| 90 | formation of translation preinitiation complex (GO:0001731) | 3.17251888 |
| 91 | mitotic spindle assembly checkpoint (GO:0007094) | 3.16924679 |
| 92 | serine family amino acid biosynthetic process (GO:0009070) | 3.16717131 |
| 93 | maturation of 5.8S rRNA (GO:0000460) | 3.15627131 |
| 94 | RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394) | 3.14807805 |
| 95 | tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388) | 3.14807805 |
| 96 | telomere maintenance via semi-conservative replication (GO:0032201) | 3.14768874 |
| 97 | protein localization to mitochondrion (GO:0070585) | 3.14391118 |
| 98 | DNA strand elongation (GO:0022616) | 3.13782548 |
| 99 | regulation of mitotic metaphase/anaphase transition (GO:0030071) | 3.13491112 |
| 100 | regulation of metaphase/anaphase transition of cell cycle (GO:1902099) | 3.13491112 |
| 101 | protein localization to kinetochore (GO:0034501) | 3.13417257 |
| 102 | establishment of chromosome localization (GO:0051303) | 3.13344329 |
| 103 | regulation of fibrinolysis (GO:0051917) | 3.13328852 |
| 104 | spliceosomal snRNP assembly (GO:0000387) | 3.11858823 |
| 105 | spindle assembly checkpoint (GO:0071173) | 3.11688071 |
| 106 | serine family amino acid metabolic process (GO:0009069) | 3.11432250 |
| 107 | indolalkylamine metabolic process (GO:0006586) | 3.11360862 |
| 108 | cell cycle G1/S phase transition (GO:0044843) | 3.11033637 |
| 109 | G1/S transition of mitotic cell cycle (GO:0000082) | 3.11033637 |
| 110 | L-methionine salvage (GO:0071267) | 3.10885870 |
| 111 | L-methionine biosynthetic process (GO:0071265) | 3.10885870 |
| 112 | amino acid salvage (GO:0043102) | 3.10885870 |
| 113 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay | 3.10730259 |
| 114 | RNA phosphodiester bond hydrolysis, exonucleolytic (GO:0090503) | 3.10221027 |
| 115 | bile acid and bile salt transport (GO:0015721) | 3.10003933 |
| 116 | regulation of chromosome segregation (GO:0051983) | 3.09956050 |
| 117 | purine nucleobase biosynthetic process (GO:0009113) | 3.06955005 |
| 118 | regulation of protein activation cascade (GO:2000257) | 3.06510126 |
| 119 | oxidative phosphorylation (GO:0006119) | 3.06470196 |
| 120 | cellular glucuronidation (GO:0052695) | 3.06071925 |
| 121 | protein deneddylation (GO:0000338) | 3.06060864 |
| 122 | nuclear pore organization (GO:0006999) | 3.05995074 |
| 123 | plasma lipoprotein particle remodeling (GO:0034369) | 3.05139979 |
| 124 | protein-lipid complex remodeling (GO:0034368) | 3.05139979 |
| 125 | macromolecular complex remodeling (GO:0034367) | 3.05139979 |
| 126 | nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291) | 3.04884140 |
| 127 | organelle disassembly (GO:1903008) | 3.04246565 |
| 128 | pseudouridine synthesis (GO:0001522) | 3.03890775 |
| 129 | complement activation, alternative pathway (GO:0006957) | 3.03676705 |
| 130 | establishment of protein localization to mitochondrion (GO:0072655) | 3.03278182 |
| 131 | regulation of mitotic sister chromatid separation (GO:0010965) | 3.02190214 |
| 132 | regulation of mitotic sister chromatid segregation (GO:0033047) | 3.02190214 |
| 133 | regulation of sister chromatid segregation (GO:0033045) | 3.02190214 |
| 134 | * negative regulation of protein ubiquitination (GO:0031397) | 3.00800227 |
| 135 | arginine metabolic process (GO:0006525) | 2.99999373 |
| 136 | proteasome assembly (GO:0043248) | 2.99841319 |
| 137 | regulation of triglyceride catabolic process (GO:0010896) | 2.97558574 |
| 138 | somatic hypermutation of immunoglobulin genes (GO:0016446) | 2.97132962 |
| 139 | somatic diversification of immune receptors via somatic mutation (GO:0002566) | 2.97132962 |
| 140 | folic acid metabolic process (GO:0046655) | 2.96630125 |
| 141 | low-density lipoprotein particle remodeling (GO:0034374) | 2.96423800 |
| 142 | negative regulation of DNA recombination (GO:0045910) | 2.95915677 |
| 143 | negative regulation of retinoic acid receptor signaling pathway (GO:0048387) | 2.95762207 |
| 144 | tRNA aminoacylation for protein translation (GO:0006418) | 2.95731828 |
| 145 | ribosomal large subunit biogenesis (GO:0042273) | 2.94965420 |
| 146 | uronic acid metabolic process (GO:0006063) | 2.94007266 |
| 147 | glucuronate metabolic process (GO:0019585) | 2.94007266 |
| 148 | amino-acid betaine metabolic process (GO:0006577) | 2.91390978 |
| 149 | tyrosine metabolic process (GO:0006570) | 2.91180319 |
| 150 | cofactor catabolic process (GO:0051187) | 2.89879590 |
| 151 | one-carbon metabolic process (GO:0006730) | 2.89453048 |
| 152 | homocysteine metabolic process (GO:0050667) | 2.84760168 |
| 153 | alpha-amino acid catabolic process (GO:1901606) | 2.84284357 |
| 154 | attachment of spindle microtubules to kinetochore (GO:0008608) | 2.83912798 |
| 155 | regulation of complement activation (GO:0030449) | 2.83452938 |
| 156 | sulfur amino acid biosynthetic process (GO:0000097) | 2.81372997 |
| 157 | fibrinolysis (GO:0042730) | 2.80887072 |
| 158 | reverse cholesterol transport (GO:0043691) | 2.79488523 |
| 159 | CENP-A containing nucleosome assembly (GO:0034080) | 2.79053102 |
| 160 | benzene-containing compound metabolic process (GO:0042537) | 2.76767555 |
| 161 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 2.76319897 |
| 162 | folic acid-containing compound biosynthetic process (GO:0009396) | 2.76168590 |
| 163 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 2.75371516 |
| 164 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 2.75371516 |
| 165 | acylglycerol homeostasis (GO:0055090) | 2.73234005 |
| 166 | triglyceride homeostasis (GO:0070328) | 2.73234005 |
| 167 | lysine catabolic process (GO:0006554) | 2.73098534 |
| 168 | lysine metabolic process (GO:0006553) | 2.73098534 |
| 169 | sulfur amino acid metabolic process (GO:0000096) | 2.71688675 |
| 170 | phospholipid efflux (GO:0033700) | 2.71215082 |
| 171 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 2.71023971 |
| 172 | imidazole-containing compound metabolic process (GO:0052803) | 2.70727543 |
| 173 | ketone body metabolic process (GO:1902224) | 2.70204003 |
| 174 | alpha-linolenic acid metabolic process (GO:0036109) | 2.70039957 |
| 175 | coenzyme catabolic process (GO:0009109) | 2.69343619 |
| 176 | primary alcohol catabolic process (GO:0034310) | 2.69117581 |
| 177 | chromatin remodeling at centromere (GO:0031055) | 2.67087701 |
| 178 | complement activation, classical pathway (GO:0006958) | 2.67071142 |
| 179 | drug catabolic process (GO:0042737) | 2.66431933 |
| 180 | urate metabolic process (GO:0046415) | 2.66314388 |
| 181 | pteridine-containing compound biosynthetic process (GO:0042559) | 2.65882583 |
| 182 | response to misfolded protein (GO:0051788) | 2.63989547 |
| 183 | chaperone-mediated protein transport (GO:0072321) | 2.62465847 |
| 184 | regulation of glucokinase activity (GO:0033131) | 2.61165088 |
| 185 | regulation of hexokinase activity (GO:1903299) | 2.61165088 |
| 186 | pyridine nucleotide biosynthetic process (GO:0019363) | 2.59452364 |
| 187 | nicotinamide nucleotide biosynthetic process (GO:0019359) | 2.59452364 |
| 188 | cellular amino acid catabolic process (GO:0009063) | 2.57323615 |
| 189 | metaphase plate congression (GO:0051310) | 2.55484245 |
| 190 | complement activation (GO:0006956) | 2.52993126 |
| 191 | NAD biosynthetic process (GO:0009435) | 2.52480760 |
| 192 | cellular aldehyde metabolic process (GO:0006081) | 2.50743770 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 5.38828292 |
| 2 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 4.12151055 |
| 3 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 4.01176763 |
| 4 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 3.76350002 |
| 5 | E2F7_22180533_ChIP-Seq_HELA_Human | 3.68576693 |
| 6 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 3.43037202 |
| 7 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 3.38260559 |
| 8 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.36327721 |
| 9 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 3.19780445 |
| 10 | * JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.91023551 |
| 11 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 2.74072365 |
| 12 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 2.59493480 |
| 13 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.57706505 |
| 14 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 2.52196841 |
| 15 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 2.46364986 |
| 16 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 2.28734110 |
| 17 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.26359408 |
| 18 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.26133148 |
| 19 | AR_21909140_ChIP-Seq_LNCAP_Human | 2.22986716 |
| 20 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.11607916 |
| 21 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.09534081 |
| 22 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 2.02028544 |
| 23 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 2.00991172 |
| 24 | * SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.99786682 |
| 25 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.98414866 |
| 26 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.96675161 |
| 27 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.94985900 |
| 28 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.93072293 |
| 29 | * MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.90496792 |
| 30 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.90223839 |
| 31 | * HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.89887546 |
| 32 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.85953253 |
| 33 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.84144697 |
| 34 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.82775595 |
| 35 | * VDR_23849224_ChIP-Seq_CD4+_Human | 1.79542819 |
| 36 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.79528908 |
| 37 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.78455926 |
| 38 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.77459678 |
| 39 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.75496481 |
| 40 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.74231928 |
| 41 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.72853091 |
| 42 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.71976103 |
| 43 | * KAP1_22055183_ChIP-Seq_ESCs_Mouse | 1.71283509 |
| 44 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.68193013 |
| 45 | * SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.67497987 |
| 46 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.66620022 |
| 47 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.64880321 |
| 48 | * FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.64023945 |
| 49 | * GABP_19822575_ChIP-Seq_HepG2_Human | 1.62965846 |
| 50 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.62771371 |
| 51 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.61115552 |
| 52 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.56317197 |
| 53 | * ELK1_19687146_ChIP-ChIP_HELA_Human | 1.55149822 |
| 54 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.48480799 |
| 55 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.42251895 |
| 56 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.35391461 |
| 57 | * MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.34393542 |
| 58 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.34354670 |
| 59 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.33819375 |
| 60 | EWS_26573619_Chip-Seq_HEK293_Human | 1.33394023 |
| 61 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.30876617 |
| 62 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.25208447 |
| 63 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.22541755 |
| 64 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.22395214 |
| 65 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.21796636 |
| 66 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.20462789 |
| 67 | VDR_22108803_ChIP-Seq_LS180_Human | 1.19463335 |
| 68 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.19135731 |
| 69 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.19000009 |
| 70 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.17622249 |
| 71 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.17106947 |
| 72 | FUS_26573619_Chip-Seq_HEK293_Human | 1.15503587 |
| 73 | * ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.15481611 |
| 74 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.11193444 |
| 75 | * CREM_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.09289094 |
| 76 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.08814646 |
| 77 | * XRN2_22483619_ChIP-Seq_HELA_Human | 1.08669197 |
| 78 | NANOG_16153702_ChIP-ChIP_HESCs_Human | 1.08461199 |
| 79 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.08302917 |
| 80 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.05897956 |
| 81 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.04911251 |
| 82 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.00419970 |
| 83 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 1.00167168 |
| 84 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 0.98374762 |
| 85 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 0.98316597 |
| 86 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 0.97772072 |
| 87 | * SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.96677122 |
| 88 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 0.95562499 |
| 89 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 0.94475318 |
| 90 | TTF2_22483619_ChIP-Seq_HELA_Human | 0.93895180 |
| 91 | * CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 0.93329672 |
| 92 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 0.93122145 |
| 93 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.92776218 |
| 94 | * SPI1_23547873_ChIP-Seq_NB4_Human | 0.92697503 |
| 95 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 0.91640979 |
| 96 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.90255410 |
| 97 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 0.89740564 |
| 98 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 0.87764852 |
| 99 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.86812172 |
| 100 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 0.86272139 |
| 101 | * ASH2L_23239880_ChIP-Seq_MESCs_Mouse | 0.85389078 |
| 102 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 0.85081904 |
| 103 | KDM5A_27292631_Chip-Seq_BREAST_Human | 0.84919858 |
| 104 | SOX17_20123909_ChIP-Seq_XEN_Mouse | 0.82985940 |
| 105 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 0.82983380 |
| 106 | * EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.82481390 |
| 107 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.81158759 |
| 108 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 0.81148679 |
| 109 | IGF1R_20145208_ChIP-Seq_DFB_Human | 0.79507881 |
| 110 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 0.79486747 |
| 111 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 0.78492602 |
| 112 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 0.77692923 |
| 113 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.76783198 |
| 114 | ELF5_23300383_ChIP-Seq_T47D_Human | 0.76697452 |
| 115 | SALL4_22934838_ChIP-ChIP_CD34+_Human | 0.76243159 |
| 116 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 0.74948589 |
| 117 | CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 0.74883706 |
| 118 | TP53_22573176_ChIP-Seq_HFKS_Human | 0.74338431 |
| 119 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 0.74303230 |
| 120 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 0.74148369 |
| 121 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 0.73552059 |
| 122 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.73483998 |
| 123 | * PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 0.72517815 |
| 124 | TRIM28_19339689_ChIP-ChIP_MESCs_Mouse | 0.71904168 |
| 125 | TBX5_21415370_ChIP-Seq_HL-1_Mouse | 0.71349527 |
| 126 | * TFEB_21752829_ChIP-Seq_HELA_Human | 0.71249462 |
| 127 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.70711771 |
| 128 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 0.70364020 |
| 129 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.69415253 |
| 130 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.67475861 |
| 131 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 0.66274982 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 6.24622208 |
| 2 | MP0005360_urolithiasis | 5.54950489 |
| 3 | MP0003806_abnormal_nucleotide_metabolis | 4.67751184 |
| 4 | MP0005085_abnormal_gallbladder_physiolo | 4.52076769 |
| 5 | MP0005365_abnormal_bile_salt | 4.15691669 |
| 6 | MP0008875_abnormal_xenobiotic_pharmacok | 3.51761453 |
| 7 | MP0003718_maternal_effect | 3.00994451 |
| 8 | MP0009840_abnormal_foam_cell | 2.97455645 |
| 9 | MP0005451_abnormal_body_composition | 2.83380684 |
| 10 | MP0003693_abnormal_embryo_hatching | 2.71226473 |
| 11 | MP0003941_abnormal_skin_development | 2.62632982 |
| 12 | MP0003186_abnormal_redox_activity | 2.43291877 |
| 13 | MP0000372_irregular_coat_pigmentation | 2.40452237 |
| 14 | MP0005083_abnormal_biliary_tract | 2.22470976 |
| 15 | MP0009697_abnormal_copulation | 2.22203197 |
| 16 | MP0002138_abnormal_hepatobiliary_system | 2.10166709 |
| 17 | MP0003252_abnormal_bile_duct | 2.07681396 |
| 18 | MP0003195_calcinosis | 2.04902028 |
| 19 | MP0003786_premature_aging | 2.03541147 |
| 20 | * MP0005332_abnormal_amino_acid | 2.00699706 |
| 21 | MP0010329_abnormal_lipoprotein_level | 1.99487514 |
| 22 | MP0010352_gastrointestinal_tract_polyps | 1.97984660 |
| 23 | MP0005408_hypopigmentation | 1.93672834 |
| 24 | MP0001764_abnormal_homeostasis | 1.91653192 |
| 25 | MP0000358_abnormal_cell_content/ | 1.88597023 |
| 26 | MP0003890_abnormal_embryonic-extraembry | 1.88570003 |
| 27 | MP0004957_abnormal_blastocyst_morpholog | 1.84852111 |
| 28 | MP0001666_abnormal_nutrient_absorption | 1.77597674 |
| 29 | MP0000350_abnormal_cell_proliferation | 1.64982902 |
| 30 | MP0003656_abnormal_erythrocyte_physiolo | 1.64960454 |
| 31 | MP0003221_abnormal_cardiomyocyte_apopto | 1.62842098 |
| 32 | MP0000569_abnormal_digit_pigmentation | 1.60729930 |
| 33 | MP0003567_abnormal_fetal_cardiomyocyte | 1.60188831 |
| 34 | MP0003436_decreased_susceptibility_to | 1.58055269 |
| 35 | MP0000609_abnormal_liver_physiology | 1.57189452 |
| 36 | MP0001835_abnormal_antigen_presentation | 1.56002124 |
| 37 | MP0004147_increased_porphyrin_level | 1.55363068 |
| 38 | MP0002090_abnormal_vision | 1.52191578 |
| 39 | MP0010094_abnormal_chromosome_stability | 1.50537746 |
| 40 | MP0010234_abnormal_vibrissa_follicle | 1.48716531 |
| 41 | MP0001929_abnormal_gametogenesis | 1.47652899 |
| 42 | MP0001697_abnormal_embryo_size | 1.44757716 |
| 43 | MP0003950_abnormal_plasma_membrane | 1.44561548 |
| 44 | MP0003191_abnormal_cellular_cholesterol | 1.40847217 |
| 45 | MP0009785_altered_susceptibility_to | 1.40511784 |
| 46 | MP0005395_other_phenotype | 1.40016275 |
| 47 | MP0005319_abnormal_enzyme/_coenzyme | 1.34049541 |
| 48 | MP0009764_decreased_sensitivity_to | 1.31043036 |
| 49 | MP0004019_abnormal_vitamin_homeostasis | 1.30018851 |
| 50 | MP0010307_abnormal_tumor_latency | 1.29418407 |
| 51 | MP0006036_abnormal_mitochondrial_physio | 1.28347879 |
| 52 | MP0001672_abnormal_embryogenesis/_devel | 1.28251499 |
| 53 | MP0005380_embryogenesis_phenotype | 1.28251499 |
| 54 | MP0003111_abnormal_nucleus_morphology | 1.24504379 |
| 55 | MP0001529_abnormal_vocalization | 1.24340553 |
| 56 | MP0003077_abnormal_cell_cycle | 1.24005383 |
| 57 | MP0002080_prenatal_lethality | 1.22869579 |
| 58 | MP0001119_abnormal_female_reproductive | 1.21653669 |
| 59 | MP0003868_abnormal_feces_composition | 1.19451194 |
| 60 | MP0000313_abnormal_cell_death | 1.18810424 |
| 61 | MP0006082_CNS_inflammation | 1.18556835 |
| 62 | MP0006054_spinal_hemorrhage | 1.17785686 |
| 63 | MP0005084_abnormal_gallbladder_morpholo | 1.17056285 |
| 64 | MP0002084_abnormal_developmental_patter | 1.16136627 |
| 65 | MP0008469_abnormal_protein_level | 1.14663473 |
| 66 | MP0004782_abnormal_surfactant_physiolog | 1.13500405 |
| 67 | MP0001293_anophthalmia | 1.13114829 |
| 68 | MP0001145_abnormal_male_reproductive | 1.10138931 |
| 69 | MP0000647_abnormal_sebaceous_gland | 1.09904128 |
| 70 | MP0002118_abnormal_lipid_homeostasis | 1.08020306 |
| 71 | MP0003724_increased_susceptibility_to | 1.07902808 |
| 72 | MP0002419_abnormal_innate_immunity | 1.07209474 |
| 73 | MP0003011_delayed_dark_adaptation | 1.05089869 |
| 74 | MP0002085_abnormal_embryonic_tissue | 1.04924184 |
| 75 | * MP0000598_abnormal_liver_morphology | 1.04737777 |
| 76 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.04580856 |
| 77 | MP0009643_abnormal_urine_homeostasis | 1.03584996 |
| 78 | MP0006072_abnormal_retinal_apoptosis | 1.03337349 |
| 79 | MP0008932_abnormal_embryonic_tissue | 1.01523336 |
| 80 | MP0008789_abnormal_olfactory_epithelium | 1.00671857 |
| 81 | * MP0009763_increased_sensitivity_to | 0.99208993 |
| 82 | MP0002160_abnormal_reproductive_system | 0.97427991 |
| 83 | MP0003984_embryonic_growth_retardation | 0.96834814 |
| 84 | MP0000015_abnormal_ear_pigmentation | 0.94821250 |
| 85 | MP0002088_abnormal_embryonic_growth/wei | 0.94565481 |
| 86 | MP0009333_abnormal_splenocyte_physiolog | 0.94536910 |
| 87 | * MP0004215_abnormal_myocardial_fiber | 0.93699546 |
| 88 | MP0001986_abnormal_taste_sensitivity | 0.93443760 |
| 89 | MP0005025_abnormal_response_to | 0.93170427 |
| 90 | MP0008058_abnormal_DNA_repair | 0.92576764 |
| 91 | MP0010368_abnormal_lymphatic_system | 0.92550850 |
| 92 | MP0005636_abnormal_mineral_homeostasis | 0.92297468 |
| 93 | MP0003646_muscle_fatigue | 0.90313089 |
| 94 | MP0006292_abnormal_olfactory_placode | 0.90286205 |
| 95 | MP0001177_atelectasis | 0.89843811 |
| 96 | MP0005376_homeostasis/metabolism_phenot | 0.89703868 |
| 97 | MP0001727_abnormal_embryo_implantation | 0.89389794 |
| 98 | MP0001845_abnormal_inflammatory_respons | 0.89371397 |
| 99 | MP0003699_abnormal_female_reproductive | 0.88531047 |
| 100 | MP0002148_abnormal_hypersensitivity_rea | 0.87057109 |
| 101 | MP0003937_abnormal_limbs/digits/tail_de | 0.86422391 |
| 102 | MP0002796_impaired_skin_barrier | 0.86323817 |
| 103 | MP0002102_abnormal_ear_morphology | 0.86290739 |
| 104 | MP0002132_abnormal_respiratory_system | 0.85651123 |
| 105 | MP0002086_abnormal_extraembryonic_tissu | 0.85532138 |
| 106 | MP0002938_white_spotting | 0.85104250 |
| 107 | MP0004233_abnormal_muscle_weight | 0.85095193 |
| 108 | MP0008007_abnormal_cellular_replicative | 0.84166798 |
| 109 | MP0005000_abnormal_immune_tolerance | 0.81622096 |
| 110 | MP0005410_abnormal_fertilization | 0.81586930 |
| 111 | MP0001800_abnormal_humoral_immune | 0.81511142 |
| 112 | * MP0005384_cellular_phenotype | 0.80845652 |
| 113 | MP0002736_abnormal_nociception_after | 0.80790625 |
| 114 | MP0005220_abnormal_exocrine_pancreas | 0.79308705 |
| 115 | MP0009765_abnormal_xenobiotic_induced | 0.77212283 |
| 116 | MP0005464_abnormal_platelet_physiology | 0.75324569 |
| 117 | MP0002019_abnormal_tumor_incidence | 0.74670486 |
| 118 | MP0002452_abnormal_antigen_presenting | 0.74581484 |
| 119 | MP0004197_abnormal_fetal_growth/weight/ | 0.73665496 |
| 120 | MP0002233_abnormal_nose_morphology | 0.73496346 |
| 121 | MP0002723_abnormal_immune_serum | 0.72737889 |
| 122 | MP0005266_abnormal_metabolism | 0.72014685 |
| 123 | MP0003698_abnormal_male_reproductive | 0.71998933 |
| 124 | MP0005647_abnormal_sex_gland | 0.70396522 |
| 125 | MP0009703_decreased_birth_body | 0.70363481 |
| 126 | MP0005501_abnormal_skin_physiology | 0.70116849 |
| 127 | MP0000604_amyloidosis | 0.69636091 |
| 128 | MP0000653_abnormal_sex_gland | 0.69615585 |
| 129 | MP0000343_altered_response_to | 0.68554271 |
| 130 | MP0002277_abnormal_respiratory_mucosa | 0.65698741 |
| 131 | * MP0009642_abnormal_blood_homeostasis | 0.65235630 |
| 132 | MP0001661_extended_life_span | 0.64976715 |
| 133 | MP0000689_abnormal_spleen_morphology | 0.64806589 |
| 134 | MP0008877_abnormal_DNA_methylation | 0.63962163 |
| 135 | MP0002876_abnormal_thyroid_physiology | 0.63687614 |
| 136 | MP0002161_abnormal_fertility/fecundity | 0.62743754 |
| 137 | * MP0008260_abnormal_autophagy | 0.62736252 |
| 138 | MP0005389_reproductive_system_phenotype | 0.61938088 |
| 139 | MP0005367_renal/urinary_system_phenotyp | 0.61424389 |
| 140 | MP0000516_abnormal_urinary_system | 0.61424389 |
| 141 | MP0005379_endocrine/exocrine_gland_phen | 0.61265732 |
| 142 | MP0005075_abnormal_melanosome_morpholog | 0.60088898 |
| 143 | MP0005387_immune_system_phenotype | 0.60035030 |
| 144 | MP0001790_abnormal_immune_system | 0.60035030 |
| 145 | MP0001533_abnormal_skeleton_physiology | 0.59338306 |
| 146 | MP0001853_heart_inflammation | 0.59315616 |
| 147 | MP0003121_genomic_imprinting | 0.58515764 |
| 148 | MP0005671_abnormal_response_to | 0.58388114 |
| 149 | * MP0008873_increased_physiological_sensi | 0.57443589 |
| 150 | MP0002163_abnormal_gland_morphology | 0.57092634 |
| 151 | MP0001188_hyperpigmentation | 0.56965910 |
| 152 | MP0001919_abnormal_reproductive_system | 0.56681831 |
| 153 | MP0001819_abnormal_immune_cell | 0.56588800 |
| 154 | MP0001915_intracranial_hemorrhage | 0.56437119 |
| 155 | MP0002282_abnormal_trachea_morphology | 0.56200765 |
| 156 | MP0000465_gastrointestinal_hemorrhage | 0.55797076 |
| 157 | MP0002420_abnormal_adaptive_immunity | 0.55577620 |
| 158 | MP0000858_altered_metastatic_potential | 0.55487732 |
| 159 | MP0006035_abnormal_mitochondrial_morpho | 0.55085392 |
| 160 | MP0008057_abnormal_DNA_replication | 0.54974838 |
| 161 | MP0000427_abnormal_hair_cycle | 0.54970535 |
| 162 | MP0000685_abnormal_immune_system | 0.54478471 |
| 163 | MP0002751_abnormal_autonomic_nervous | 0.53755564 |
| 164 | MP0001881_abnormal_mammary_gland | 0.53416552 |
| 165 | MP0002210_abnormal_sex_determination | 0.52978123 |
| 166 | MP0001730_embryonic_growth_arrest | 0.52745483 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 5.42465253 |
| 2 | Hypobetalipoproteinemia (HP:0003563) | 5.11567691 |
| 3 | Deep venous thrombosis (HP:0002625) | 4.86645948 |
| 4 | Intrahepatic cholestasis (HP:0001406) | 4.84076372 |
| 5 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 4.60101077 |
| 6 | Prolonged partial thromboplastin time (HP:0003645) | 4.28298877 |
| 7 | Xanthomatosis (HP:0000991) | 3.74758399 |
| 8 | Type I transferrin isoform profile (HP:0003642) | 3.62343244 |
| 9 | Hyperglycinemia (HP:0002154) | 3.56029043 |
| 10 | Abnormality of methionine metabolism (HP:0010901) | 3.54594538 |
| 11 | Abnormality of alanine metabolism (HP:0010916) | 3.51719753 |
| 12 | Hyperalaninemia (HP:0003348) | 3.51719753 |
| 13 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 3.51719753 |
| 14 | Hypolipoproteinemia (HP:0010981) | 3.39700149 |
| 15 | Joint hemorrhage (HP:0005261) | 3.37404794 |
| 16 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.32242734 |
| 17 | Fat malabsorption (HP:0002630) | 3.30011460 |
| 18 | Hyperammonemia (HP:0001987) | 3.28572110 |
| 19 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.28190578 |
| 20 | Degeneration of anterior horn cells (HP:0002398) | 3.23516959 |
| 21 | Abnormality of the anterior horn cell (HP:0006802) | 3.23516959 |
| 22 | Abnormal protein N-linked glycosylation (HP:0012347) | 3.21350864 |
| 23 | Abnormal protein glycosylation (HP:0012346) | 3.21350864 |
| 24 | Abnormal glycosylation (HP:0012345) | 3.21350864 |
| 25 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 3.21350864 |
| 26 | Multiple enchondromatosis (HP:0005701) | 3.14498432 |
| 27 | Abnormality of the common coagulation pathway (HP:0010990) | 3.13416335 |
| 28 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.10231031 |
| 29 | Complement deficiency (HP:0004431) | 3.10128902 |
| 30 | Hyperlipoproteinemia (HP:0010980) | 3.04915217 |
| 31 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.98954406 |
| 32 | Microvesicular hepatic steatosis (HP:0001414) | 2.93704578 |
| 33 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.93567826 |
| 34 | Conjugated hyperbilirubinemia (HP:0002908) | 2.90965192 |
| 35 | Abnormality of serum amino acid levels (HP:0003112) | 2.89831399 |
| 36 | Steatorrhea (HP:0002570) | 2.88602504 |
| 37 | Abnormality of the intrinsic pathway (HP:0010989) | 2.88328801 |
| 38 | Medulloblastoma (HP:0002885) | 2.79168023 |
| 39 | Increased serum pyruvate (HP:0003542) | 2.78898996 |
| 40 | Abnormality of glycolysis (HP:0004366) | 2.78898996 |
| 41 | Cerebral edema (HP:0002181) | 2.77817544 |
| 42 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 2.77504288 |
| 43 | Ependymoma (HP:0002888) | 2.77140293 |
| 44 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.74111153 |
| 45 | Lethargy (HP:0001254) | 2.73320568 |
| 46 | Hyperglycinuria (HP:0003108) | 2.72123689 |
| 47 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.71595706 |
| 48 | Chromsome breakage (HP:0040012) | 2.70811728 |
| 49 | Birth length less than 3rd percentile (HP:0003561) | 2.69511021 |
| 50 | Acute encephalopathy (HP:0006846) | 2.64745074 |
| 51 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.64078557 |
| 52 | Abnormality of glycine metabolism (HP:0010895) | 2.64078557 |
| 53 | Agnosia (HP:0010524) | 2.59566331 |
| 54 | Meckel diverticulum (HP:0002245) | 2.56377327 |
| 55 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.56080605 |
| 56 | Abnormality of chromosome stability (HP:0003220) | 2.55648440 |
| 57 | Abnormality of the labia minora (HP:0012880) | 2.53236515 |
| 58 | Colon cancer (HP:0003003) | 2.52497553 |
| 59 | Hepatic necrosis (HP:0002605) | 2.50866487 |
| 60 | Rhabdomyosarcoma (HP:0002859) | 2.49947795 |
| 61 | Abnormality of the ileum (HP:0001549) | 2.49716019 |
| 62 | Abnormality of the preputium (HP:0100587) | 2.48853837 |
| 63 | Hyperbilirubinemia (HP:0002904) | 2.45976590 |
| 64 | Glioma (HP:0009733) | 2.45584764 |
| 65 | Abnormality of nucleobase metabolism (HP:0010932) | 2.45167455 |
| 66 | Abnormality of complement system (HP:0005339) | 2.41186648 |
| 67 | Hypoalphalipoproteinemia (HP:0003233) | 2.39754768 |
| 68 | Stenosis of the external auditory canal (HP:0000402) | 2.38459035 |
| 69 | Ketosis (HP:0001946) | 2.35561585 |
| 70 | Systemic lupus erythematosus (HP:0002725) | 2.35428552 |
| 71 | Abnormal lung lobation (HP:0002101) | 2.35363799 |
| 72 | Recurrent bacterial skin infections (HP:0005406) | 2.34875262 |
| 73 | Neoplasm of the adrenal gland (HP:0100631) | 2.33701709 |
| 74 | Neoplasm of the colon (HP:0100273) | 2.31620839 |
| 75 | Epidermoid cyst (HP:0200040) | 2.31368678 |
| 76 | Breast hypoplasia (HP:0003187) | 2.31344639 |
| 77 | Posterior subcapsular cataract (HP:0007787) | 2.29993478 |
| 78 | Oral leukoplakia (HP:0002745) | 2.29869979 |
| 79 | Reduced antithrombin III activity (HP:0001976) | 2.28221242 |
| 80 | Abnormality of urine glucose concentration (HP:0011016) | 2.27452490 |
| 81 | Glycosuria (HP:0003076) | 2.27452490 |
| 82 | Secondary amenorrhea (HP:0000869) | 2.26974102 |
| 83 | Spontaneous abortion (HP:0005268) | 2.26581039 |
| 84 | Hepatocellular necrosis (HP:0001404) | 2.26563762 |
| 85 | Acute necrotizing encephalopathy (HP:0006965) | 2.26534107 |
| 86 | Duodenal stenosis (HP:0100867) | 2.24917570 |
| 87 | Small intestinal stenosis (HP:0012848) | 2.24917570 |
| 88 | Sparse eyelashes (HP:0000653) | 2.22999430 |
| 89 | Facial cleft (HP:0002006) | 2.19625623 |
| 90 | Hypoglycemic coma (HP:0001325) | 2.18775741 |
| 91 | Vacuolated lymphocytes (HP:0001922) | 2.18692556 |
| 92 | Aplasia/Hypoplasia of the uvula (HP:0010293) | 2.18046590 |
| 93 | Premature ovarian failure (HP:0008209) | 2.17893363 |
| 94 | Irregular epiphyses (HP:0010582) | 2.16295492 |
| 95 | Short tibia (HP:0005736) | 2.15071408 |
| 96 | Atrophy/Degeneration involving motor neurons (HP:0007373) | 2.13962278 |
| 97 | Lipid accumulation in hepatocytes (HP:0006561) | 2.13833587 |
| 98 | Increased CSF lactate (HP:0002490) | 2.11855764 |
| 99 | Generalized aminoaciduria (HP:0002909) | 2.11648237 |
| 100 | Abnormality of the astrocytes (HP:0100707) | 2.10979918 |
| 101 | Astrocytoma (HP:0009592) | 2.10979918 |
| 102 | Papillary thyroid carcinoma (HP:0002895) | 2.10218029 |
| 103 | Metabolic acidosis (HP:0001942) | 2.09249958 |
| 104 | Median cleft lip (HP:0000161) | 2.07712588 |
| 105 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.07677508 |
| 106 | Malnutrition (HP:0004395) | 2.07119251 |
| 107 | Supernumerary spleens (HP:0009799) | 2.06895102 |
| 108 | Dicarboxylic aciduria (HP:0003215) | 2.06888824 |
| 109 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.06888824 |
| 110 | Exercise intolerance (HP:0003546) | 2.04594648 |
| 111 | Glomerulonephritis (HP:0000099) | 2.03920457 |
| 112 | Biliary tract neoplasm (HP:0100574) | 2.03859734 |
| 113 | Mitochondrial inheritance (HP:0001427) | 2.03758088 |
| 114 | Hypercholesterolemia (HP:0003124) | 2.02208605 |
| 115 | Abnormality of purine metabolism (HP:0004352) | 2.01629815 |
| 116 | Increased hepatocellular lipid droplets (HP:0006565) | 2.00809678 |
| 117 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.00729035 |
| 118 | Renal Fanconi syndrome (HP:0001994) | 2.00614317 |
| 119 | Hepatocellular carcinoma (HP:0001402) | 2.00194870 |
| 120 | Carpal bone hypoplasia (HP:0001498) | 1.99028434 |
| 121 | Proximal tubulopathy (HP:0000114) | 1.97501706 |
| 122 | Neoplasm of the small intestine (HP:0100833) | 1.97296183 |
| 123 | CNS demyelination (HP:0007305) | 1.96638832 |
| 124 | Increased serum lactate (HP:0002151) | 1.94905933 |
| 125 | Nephroblastoma (Wilms tumor) (HP:0002667) | 1.94834776 |
| 126 | Embryonal renal neoplasm (HP:0011794) | 1.93852175 |
| 127 | Recurrent abscess formation (HP:0002722) | 1.92805830 |
| 128 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 1.92347671 |
| 129 | Methylmalonic aciduria (HP:0012120) | 1.91738806 |
| 130 | Aplastic anemia (HP:0001915) | 1.91012238 |
| 131 | Breast carcinoma (HP:0003002) | 1.90858209 |
| 132 | Methylmalonic acidemia (HP:0002912) | 1.89849797 |
| 133 | Cerebral hypomyelination (HP:0006808) | 1.89679840 |
| 134 | Aplasia/hypoplasia of the uterus (HP:0008684) | 1.87731893 |
| 135 | Cortical dysplasia (HP:0002539) | 1.87065969 |
| 136 | Lactic acidosis (HP:0003128) | 1.85964066 |
| 137 | Neoplasm of the rectum (HP:0100743) | 1.84690248 |
| 138 | Respiratory failure (HP:0002878) | 1.84518895 |
| 139 | Irritability (HP:0000737) | 1.84067220 |
| 140 | Sensory axonal neuropathy (HP:0003390) | 1.84012959 |
| 141 | Gout (HP:0001997) | 1.83320839 |
| 142 | Tongue fasciculations (HP:0001308) | 1.82936008 |
| 143 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 1.82769056 |
| 144 | Brushfield spots (HP:0001088) | 1.82661843 |
| 145 | 3-Methylglutaconic aciduria (HP:0003535) | 1.82265060 |
| 146 | Abnormality of the duodenum (HP:0002246) | 1.81459920 |
| 147 | Autoamputation (HP:0001218) | 1.79881828 |
| 148 | Respiratory difficulties (HP:0002880) | 1.79690630 |
| 149 | Amniotic constriction ring (HP:0009775) | 1.79535716 |
| 150 | Abnormality of placental membranes (HP:0011409) | 1.79535716 |
| 151 | Myocardial infarction (HP:0001658) | 1.79356121 |
| 152 | Exertional dyspnea (HP:0002875) | 1.78669738 |
| 153 | Nausea (HP:0002018) | 1.77303226 |
| 154 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 1.76641472 |
| 155 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 1.76641472 |
| 156 | Pancreatitis (HP:0001733) | 1.75756126 |
| 157 | Megaloblastic anemia (HP:0001889) | 1.74796232 |
| 158 | Progressive macrocephaly (HP:0004481) | 1.74782475 |
| 159 | Progressive inability to walk (HP:0002505) | 1.74440919 |
| 160 | Flat capital femoral epiphysis (HP:0003370) | 1.73548318 |
| 161 | Hyperphosphaturia (HP:0003109) | 1.73321303 |
| 162 | Renal cortical cysts (HP:0000803) | 1.72820291 |
| 163 | Postnatal microcephaly (HP:0005484) | 1.72803238 |
| 164 | Vomiting (HP:0002013) | 1.70985744 |
| 165 | Eczematoid dermatitis (HP:0000976) | 1.70421212 |
| 166 | CNS hypomyelination (HP:0003429) | 1.70163457 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EIF2AK1 | 3.21661132 |
| 2 | ARAF | 3.04933067 |
| 3 | ZAK | 2.82125571 |
| 4 | PLK4 | 2.79761012 |
| 5 | BCKDK | 2.78748633 |
| 6 | TRIM28 | 2.72424352 |
| 7 | TAOK3 | 2.70884374 |
| 8 | STK38L | 2.69236137 |
| 9 | ERBB4 | 2.66585577 |
| 10 | BUB1 | 2.56494139 |
| 11 | BRAF | 2.52650906 |
| 12 | MAP3K12 | 2.42601364 |
| 13 | BMPR2 | 2.29862351 |
| 14 | PDK2 | 2.21673274 |
| 15 | EIF2AK3 | 2.21314524 |
| 16 | PBK | 2.06756270 |
| 17 | NME2 | 2.00303643 |
| 18 | MAP4K2 | 1.96104891 |
| 19 | MOS | 1.93381157 |
| 20 | ABL2 | 1.91200829 |
| 21 | STK16 | 1.81306034 |
| 22 | MAP3K6 | 1.76914192 |
| 23 | PIM2 | 1.71403275 |
| 24 | TTK | 1.71172859 |
| 25 | MST4 | 1.70129134 |
| 26 | LATS1 | 1.70120094 |
| 27 | LATS2 | 1.68886847 |
| 28 | CDK8 | 1.68262467 |
| 29 | NEK9 | 1.65929824 |
| 30 | ERBB3 | 1.56649724 |
| 31 | MAP3K3 | 1.55165205 |
| 32 | MAP3K14 | 1.53641960 |
| 33 | ACVR1B | 1.52370596 |
| 34 | WEE1 | 1.39643277 |
| 35 | FLT3 | 1.38830464 |
| 36 | CDK19 | 1.30152589 |
| 37 | TYK2 | 1.28972136 |
| 38 | PLK1 | 1.27944120 |
| 39 | STK39 | 1.27388657 |
| 40 | VRK2 | 1.26560970 |
| 41 | RAF1 | 1.24128180 |
| 42 | MAPKAPK3 | 1.23401235 |
| 43 | BRSK2 | 1.22076152 |
| 44 | SCYL2 | 1.20881505 |
| 45 | MKNK2 | 1.18086433 |
| 46 | VRK1 | 1.17726866 |
| 47 | IRAK3 | 1.17400547 |
| 48 | SRPK1 | 1.17231205 |
| 49 | BRSK1 | 1.13299670 |
| 50 | RPS6KA4 | 1.12620347 |
| 51 | CDC7 | 1.12228984 |
| 52 | STK3 | 1.09243159 |
| 53 | TAF1 | 1.08255927 |
| 54 | AURKA | 1.07173623 |
| 55 | PAK4 | 1.05459501 |
| 56 | DYRK2 | 1.05034049 |
| 57 | PIK3CG | 1.04919599 |
| 58 | OXSR1 | 1.04682276 |
| 59 | MAP3K13 | 1.04064884 |
| 60 | CSNK1G2 | 1.03866329 |
| 61 | IRAK4 | 1.03062190 |
| 62 | MELK | 1.02683841 |
| 63 | CSNK1A1L | 0.98562099 |
| 64 | STK24 | 0.97368292 |
| 65 | STK10 | 0.96035464 |
| 66 | TBK1 | 0.95449510 |
| 67 | AURKB | 0.94878601 |
| 68 | NLK | 0.94411487 |
| 69 | PLK3 | 0.87070879 |
| 70 | CCNB1 | 0.86473007 |
| 71 | MAP3K8 | 0.86290739 |
| 72 | ATR | 0.84980361 |
| 73 | JAK3 | 0.84423390 |
| 74 | PIM1 | 0.83613606 |
| 75 | NEK2 | 0.83381344 |
| 76 | NUAK1 | 0.81956286 |
| 77 | MUSK | 0.81817754 |
| 78 | PLK2 | 0.79242546 |
| 79 | MAP3K5 | 0.77402691 |
| 80 | MAPK11 | 0.77243859 |
| 81 | IKBKB | 0.75493145 |
| 82 | PNCK | 0.71434871 |
| 83 | CSNK1G3 | 0.70415704 |
| 84 | TLK1 | 0.70319453 |
| 85 | KIT | 0.69324292 |
| 86 | NME1 | 0.68945523 |
| 87 | TNIK | 0.68414098 |
| 88 | WNK3 | 0.67747424 |
| 89 | CSNK1G1 | 0.66865485 |
| 90 | EIF2AK2 | 0.64745023 |
| 91 | CLK1 | 0.64549460 |
| 92 | DAPK1 | 0.63971344 |
| 93 | CHEK2 | 0.63655284 |
| 94 | IKBKE | 0.62480345 |
| 95 | NEK6 | 0.59514494 |
| 96 | TESK1 | 0.58092782 |
| 97 | ATM | 0.57487392 |
| 98 | CHEK1 | 0.56948290 |
| 99 | BMPR1B | 0.56655922 |
| 100 | MYLK | 0.56460905 |
| 101 | KSR2 | 0.55971989 |
| 102 | SIK3 | 0.55782100 |
| 103 | LIMK1 | 0.53523798 |
| 104 | TRPM7 | 0.52082417 |
| 105 | TEC | 0.51928990 |
| 106 | CSNK2A1 | 0.51746382 |
| 107 | MET | 0.50766903 |
| 108 | DYRK3 | 0.50659512 |
| 109 | TXK | 0.49090979 |
| 110 | CSNK2A2 | 0.48187942 |
| 111 | MINK1 | 0.47320547 |
| 112 | CDK7 | 0.47234876 |
| 113 | MAP2K3 | 0.46787255 |
| 114 | KDR | 0.46272699 |
| 115 | CDK4 | 0.43151099 |
| 116 | BCR | 0.42644772 |
| 117 | MAP3K4 | 0.42353261 |
| 118 | TGFBR1 | 0.41235800 |
| 119 | MAP3K11 | 0.41027394 |
| 120 | CSF1R | 0.40831423 |
| 121 | FGFR4 | 0.40706333 |
| 122 | LYN | 0.40681973 |
| 123 | EGFR | 0.40620395 |
| 124 | PASK | 0.38581134 |
| 125 | NEK1 | 0.38303631 |
| 126 | GRK7 | 0.37348449 |
| 127 | JAK2 | 0.36880339 |
| 128 | CHUK | 0.36352416 |
| 129 | ILK | 0.35861726 |
| 130 | CDK6 | 0.34377486 |
| 131 | STK4 | 0.34160914 |
| 132 | MAPK4 | 0.33783580 |
| 133 | TAOK2 | 0.33688573 |
| 134 | GRK6 | 0.33128009 |
| 135 | MST1R | 0.32568188 |
| 136 | ABL1 | 0.32473352 |
| 137 | TESK2 | 0.31750828 |
| 138 | TSSK6 | 0.31484027 |
| 139 | MAP4K1 | 0.31083452 |
| 140 | KSR1 | 0.28682754 |
| 141 | CSNK1E | 0.28117904 |
| 142 | CDK14 | 0.27454711 |
| 143 | RPS6KB2 | 0.27260871 |
| 144 | MKNK1 | 0.27203511 |
| 145 | CDK18 | 0.25674164 |
| 146 | PAK1 | 0.24843737 |
| 147 | PAK3 | 0.24176925 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.36888071 |
| 2 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.75036430 |
| 3 | Proteasome_Homo sapiens_hsa03050 | 2.28396675 |
| 4 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.25257195 |
| 5 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.18095886 |
| 6 | Folate biosynthesis_Homo sapiens_hsa00790 | 2.11250091 |
| 7 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.07529985 |
| 8 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.04203714 |
| 9 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 2.03490204 |
| 10 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.01631731 |
| 11 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.94593912 |
| 12 | Peroxisome_Homo sapiens_hsa04146 | 1.92584019 |
| 13 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.91390261 |
| 14 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.91175761 |
| 15 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.89345243 |
| 16 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.85784720 |
| 17 | Protein export_Homo sapiens_hsa03060 | 1.78265574 |
| 18 | RNA polymerase_Homo sapiens_hsa03020 | 1.75703127 |
| 19 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.70654314 |
| 20 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.69204356 |
| 21 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.68116171 |
| 22 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.60711928 |
| 23 | Histidine metabolism_Homo sapiens_hsa00340 | 1.60024990 |
| 24 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.59957203 |
| 25 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.59783131 |
| 26 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.57759847 |
| 27 | DNA replication_Homo sapiens_hsa03030 | 1.55331766 |
| 28 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.53720752 |
| 29 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.53335319 |
| 30 | Retinol metabolism_Homo sapiens_hsa00830 | 1.48654043 |
| 31 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.47493723 |
| 32 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.47227810 |
| 33 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.46596171 |
| 34 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.45909119 |
| 35 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.45564467 |
| 36 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.41985121 |
| 37 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.38296868 |
| 38 | Homologous recombination_Homo sapiens_hsa03440 | 1.32370243 |
| 39 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.26998279 |
| 40 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.25225777 |
| 41 | Mismatch repair_Homo sapiens_hsa03430 | 1.24337684 |
| 42 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 1.24233883 |
| 43 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.22441440 |
| 44 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.21935520 |
| 45 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.21563516 |
| 46 | Alzheimers disease_Homo sapiens_hsa05010 | 1.20669944 |
| 47 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.20445780 |
| 48 | Basal transcription factors_Homo sapiens_hsa03022 | 1.16868893 |
| 49 | Oocyte meiosis_Homo sapiens_hsa04114 | 1.16496499 |
| 50 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.14556385 |
| 51 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.12275658 |
| 52 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.11983701 |
| 53 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.10980414 |
| 54 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.09781915 |
| 55 | Sulfur relay system_Homo sapiens_hsa04122 | 1.04461400 |
| 56 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.04321088 |
| 57 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.02861022 |
| 58 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.02540227 |
| 59 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.01471486 |
| 60 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.99633473 |
| 61 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.96530179 |
| 62 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.95793415 |
| 63 | Base excision repair_Homo sapiens_hsa03410 | 0.94270569 |
| 64 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.94202083 |
| 65 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.93782166 |
| 66 | RNA degradation_Homo sapiens_hsa03018 | 0.92508677 |
| 67 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.92319245 |
| 68 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.90723400 |
| 69 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.90567160 |
| 70 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.89552335 |
| 71 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.88761192 |
| 72 | Cell cycle_Homo sapiens_hsa04110 | 0.88743049 |
| 73 | Ribosome_Homo sapiens_hsa03010 | 0.88680629 |
| 74 | Carbon metabolism_Homo sapiens_hsa01200 | 0.86640413 |
| 75 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.85440705 |
| 76 | Other glycan degradation_Homo sapiens_hsa00511 | 0.85267218 |
| 77 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.84588686 |
| 78 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.81495441 |
| 79 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.79935975 |
| 80 | * Regulation of autophagy_Homo sapiens_hsa04140 | 0.79372836 |
| 81 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.78814865 |
| 82 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.73835095 |
| 83 | RNA transport_Homo sapiens_hsa03013 | 0.73044523 |
| 84 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.71746546 |
| 85 | Metabolic pathways_Homo sapiens_hsa01100 | 0.70833889 |
| 86 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.69580811 |
| 87 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.68659466 |
| 88 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.59378697 |
| 89 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.59114997 |
| 90 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.56940136 |
| 91 | Legionellosis_Homo sapiens_hsa05134 | 0.56194272 |
| 92 | Purine metabolism_Homo sapiens_hsa00230 | 0.52075513 |
| 93 | Parkinsons disease_Homo sapiens_hsa05012 | 0.51978242 |
| 94 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.51073651 |
| 95 | * Shigellosis_Homo sapiens_hsa05131 | 0.50469248 |
| 96 | Galactose metabolism_Homo sapiens_hsa00052 | 0.48874757 |
| 97 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.48010003 |
| 98 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.45444408 |
| 99 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.44433312 |
| 100 | Circadian rhythm_Homo sapiens_hsa04710 | 0.40793531 |
| 101 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.39940870 |
| 102 | Bile secretion_Homo sapiens_hsa04976 | 0.39225493 |
| 103 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.39201426 |
| 104 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.38405886 |
| 105 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.37261929 |
| 106 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.36846792 |
| 107 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.36021529 |
| 108 | ABC transporters_Homo sapiens_hsa02010 | 0.35461087 |
| 109 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.33947555 |
| 110 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.32395400 |
| 111 | Huntingtons disease_Homo sapiens_hsa05016 | 0.31781348 |
| 112 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.31292731 |
| 113 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.30942614 |
| 114 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.30533029 |
| 115 | Spliceosome_Homo sapiens_hsa03040 | 0.30318266 |
| 116 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.25376759 |
| 117 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.25132717 |
| 118 | Phototransduction_Homo sapiens_hsa04744 | 0.19281568 |
| 119 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.18820019 |
| 120 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.16336910 |
| 121 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.14377679 |
| 122 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.10642833 |
| 123 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.08677327 |

